Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) Net Income towards Common Stockholders (2017 - 2025)

Historic Net Income towards Common Stockholders for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to -$780000.0.

  • ENvue Medical's Net Income towards Common Stockholders rose 2184.37% to -$780000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year decrease of 6864.27%. This contributed to the annual value of -$3.7 million for FY2024, which is 16.17% up from last year.
  • ENvue Medical's Net Income towards Common Stockholders amounted to -$780000.0 in Q3 2025, which was up 2184.37% from -$500000.0 recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's Net Income towards Common Stockholders ranged from a high of -$230000.0 in Q2 2021 and a low of -$6.7 million during Q3 2021
  • Over the past 5 years, ENvue Medical's median Net Income towards Common Stockholders value was -$1.1 million (recorded in 2023), while the average stood at -$1.6 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 62386.12% in 2021, then skyrocketed by 8569.07% in 2022.
  • Over the past 5 years, ENvue Medical's Net Income towards Common Stockholders (Quarter) stood at -$2.5 million in 2021, then rose by 16.54% to -$2.1 million in 2022, then soared by 60.51% to -$813000.0 in 2023, then plummeted by 76.01% to -$1.4 million in 2024, then soared by 45.49% to -$780000.0 in 2025.
  • Its last three reported values are -$780000.0 in Q3 2025, -$500000.0 for Q2 2025, and -$2.5 million during Q1 2025.